Effect of ınhaler Use on Oral Health in COPD Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-80
SponsorÇankırı Karatekin University
About this trial
The aim of this study was to evaluate the effect of oral health education given to individuals diagnosed with COPD and using inhaled medication.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with COPD for at least 6 months,
Outpatient and inpatient,
Consent to participate in the research,
Not under the age of eighteen,
Disqualifiers
Diagnosed with COPD for less than 6 months,
Refused to participate in the research,
Treatment without metered dose inhalers (MDIs),
Uncommunicative,
Trial design
Design model
Single group
Treatments tested in this trial
Mouth Care Training
Other interventionPatients will be educated on how to care for their mouths after using inhaled medication.
Treatment groups
80 Participants
are divided into 1 treatment groupGroup A: DENEY GRUBUOther 1 intervention
Trial outcomes
Primary outcomes
1
Oral Health Status with Oral Assessment Guide
Oral health status will be assessed using the Oral Assessment Guide. After the training, the scores of the trained group and the untrained group will be compared to determine the effect of oral care training. Each change in oral health is scored between 1 and 3 points and these points are added to obtain a total score. The guide supports the creation of an oral care protocol for a patient with a deteriorated oral mucous membrane. The scores that can be obtained from the guide vary between 8 and 24. A total oral mucous membrane score (OMP) between 8 and 14 indicates "oral-mucous membrane deterioration risk", while a score between 14 and 24 indicates "oral mucous membrane deterioration". According to the oral assessment guide, individuals with low scores indicate that their oral health is good, while high scores indicate a negative change in oral health.
Time frame
Baseline and 3 months after interventionSecondary outcomes
1
Medication Adherence with Medication Adherence Reporting Scale
Patients' compliance with inhaler use will be assessed using the Medication Adherence Reporting Scale. There are 5 items in the scale. A 5-point Likert-type scale (1=always, 5=never) is used for responses. The scores that can be obtained from the scale vary between 5 and 25. An increase in the total score of the scale indicates increased medication compliance, while a decrease in the score indicates decreased medication compliance.
Time frame
Baseline and 3 months after interventionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov